Leading with its benchmark facilities serving the CRAMs industry, we offer a comprehensive array of dedicated services under its contract manufacturing model that are now available for finished dosage forms.
Our Formulations Capability:
- Liquid formulations - Unit 10 Bavla, India - 4450m2 of total constructed area
- Soft Gel Capsules - Unit 10 Bavla, India - over 2780m2 of total built-in area
Liquid Formulations:
- A dedicated manufacturing facility of hygiene care formulation products and hospital-grade disinfectants
- Reliable supply as in-house APIs manufacturing
- Different packing type, colour, or fragrance according to customer's requirement
- WHO-GMP certification
- ISO 13485 for Medical Devices complied
Soft Gel Capsules:
Dishman Carbogen Amcis Ltd has largely indulged in developing sophisticated infrastructure, enabling the production of various novel dosage formulations in soft gelatin capsules, such as Therapeutic, Nutraceutical, and OTC.
- Pilot Softgel facility - 500m2 with 30 million capsules per annum capacity
- Commercial softgel facility - 2320m2 with 300 million capsules per annum capacity
- The plant is designed to meet the highest regulatory quality standards, including EU, USFDA, WHO GMP